Predictive potential of twenty-two biochemical biomarkers for coronary artery disease in type 2 diabetes mellitus

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Pereira, Edimar Cristiano ^a,b   Bertolami, Marcelo Chiara ^c   Faludi, André Arpad ^c   Monte, Osmar ^d   Xavier, Hermes Toros ^e   Pereira, Tiago Veiga ^a,f   Abdalla, Dulcineia Saes Parra ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d Universidade de Santos   (Brazil)

^e Santa Casa de São Paulo and Hospital Santa Isabel   (Brazil)

^f HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

6 N,N' DIMETHYLARGININE; ARGININE; BIOCHEMICAL BIOMARKER; BIOLOGICAL MARKER; CYSTEINE; FRUCTOSAMINE; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE; N ACETYL BETA GLUCOSAMINIDASE; N(G),N(G) DIMETHYLARGININE; NITRATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; BRAZILIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84930637758     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/146816     Document Type: Article

References (39)

1. J. H. Pinkney, C. D. A. Stehouwer, S.W. Coppack, and J. S. Yudkin, "Endothelial dysfunction: cause of the insulin resistance syndrome," Diabetes, vol. 46, no. 2, pp. S9-S13, 1997.
2. F. Cosentino and T. F. Luscher, "Endothelial dysfunction in diabetes mellitus," Journal of Cardiovascular Pharmacology, vol. 32, no. 3, pp. S54-S61, 1998.
3. M. M. Gabir, R. L. Hanson,D.Dabelea et al., "The 1997American Diabetes Association and 1999World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes," Diabetes Care, vol. 23, no. 8, pp. 1108-1112, 2000.
4. A. Reglero and J. A. Cabezas, "Glycosidases of molluscs. Purification and properties of α L fucosidase from Chamelea gallina L.," European Journal of Biochemistry, vol. 66, no. 2, pp. 379-387, 1976.
5. J. F. Ewing andD. R. Janero, "Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium(III) reduction and ozone-chemiluminescent detection," Free Radical Biology and Medicine, vol. 25, no. 4-5, pp. 621-628, 1998.
6. R. Marley, M. Feelisch, S. Holt, and K. Moore, "A chemiluminescense-based assay for S-nitrosoalbumin and other plasma S-nitrosothiols," Free Radical Research, vol. 32, no. 1, pp. 1-9, 2000.
7. E. Causs'e, N. Siri, J. F. Arnal et al., "Determination of asymmetrical dimethylarginine by capillary electrophoresis-laserinduced fluorescence," Journal of ChromatographyB: Biomedical Sciences and Applications, vol. 741, no. 1, pp. 77-83, 2000.
8. G. Vecchione, M. Margaglione, E. Grandone et al., "Determining sulfur-containing amino acids by capillary electrophoresis: a fast novel method for total homocyst(e)ine human plasma," Electrophoresis, vol. 20, no. 3, pp. 569-574, 1999.
9. G. J. Chakmakjian, Endocrinology, Laboratory Medicine, Philadelphia, Pa, USA, 1982.
10. A. H. Fielding and J. F. Bell, "A review ofmethods for the assessment of prediction errors in conservation presence/absence models," Environmental Conservation, vol. 24, no. 1, pp. 38-49, 1997.
11. W. S. Bush, T. L. Edwards, S.M.Dudek, B. A.McKinney, and M. D. Ritchie, "Alternative contingency tablemeasures improve the power and detection of multifactor dimensionality reduction," BMC Bioinformatics, vol. 9, article 238, 2008.
12. W. Bouwmeester, N. P. A. Zuithoff, S. Mallett et al., "Reporting and methods in clinical prediction research: a systematic review," PLoS Medicine, vol. 9, no. 5,Article ID e1001221, 2012.
13. T. V. Pereira, M. Rudnicki, R. F. Franco, A. C. Pereira, and J. E. Krieger, "Effect of the G-308A polymorphism of the tumor necrosis factor α gene on the risk of ischemic heart disease and ischemic stroke: a meta-analysis,"The American Heart Journal, vol. 153, no. 5, pp. 821-830, 2007.
14. T. V. Pereira, R. I. Horwitz, and J. P. A. Ioannidis, "Empirical evaluation of very large treatment effects of medical interventions," The Journal of theAmericanMedical Association, vol. 308, no. 16, pp. 1676-1684, 2012.
15. G. S. Collins, S. Mallett, O. Omar, and L. M. Yu, "Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting," BMC Medicine, vol. 9, article 103, 2011.
16. E. C. Pereira, S. Ferderbar, M. C. Bertolami et al., "Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus," Clinical Biochemistry, vol. 41, no. 18, pp. 1454-1460, 2008.
17. J. L.Witztum, "The oxidation hypothesis of atherosclerosis,"The Lancet, vol. 344, no. 8925, pp. 793-795, 1994.
18. N. Hogg, V. M. Darley-Usmar, A. Graham, and S. Moncada, "Peroxynitrite and atherosclerosis," Biochemistry of Society Transplant, vol. 21, no. 2, pp. 358-362, 1993.
19. S. P. Wolff and R. T. Dean, "Glucose autoxidation and protein modification. The potential role of "autoxidative glycosylation" in diabetes," Biochemical Journal, vol. 245, no. 1, pp. 243-250, 1987.
20. J. Farkas and E. J. Menzel, "Proteins lose their nitric oxide stabilizing function after advanced glycosylation," Biochimica et Biophysica Acta-General Subjects, vol. 1245, no. 3, pp. 305-310, 1995.
21. J. S. Johansen, A. K.Harris,D. J.Rychly, andA.Ergul, "Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice," Cardiovascular Diabetology, vol. 4, article 5, pp. 1-11, 2005.
22. N. Hogg, V. M. Darley-Usmar,M. T.Wilson, and S.Moncada, "The oxidation of α-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide," FEBS Letters, vol. 326, no. 1-3, pp. 199-203, 1993.
23. O. Augusto, R. M. Gatti, and R. Radi, "Spin-trapping studies of peroxynitrite decomposition and of 3-morpholinosydnonimine N-ethylcarbamide autooxidation: direct evidence for metalindependent formation of free radical intermediates," Archives of Biochemistry and Biophysics, vol. 310, no. 1, pp. 118-125, 1994.
24. B. Balint, S. A. Kharitonov, T. Hanazawa et al., "Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis," European Respiratory Journal, vol. 17, no. 6, pp. 1201-1207, 2001.
25. E. K. Hoogeveen, P. J. Kostense, C. Jakobs et al., "Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of theHoorn study," Circulation, vol. 101, no. 13, pp. 1506-1511, 2000.
26. Y. Xiong, M. Lei, S. Fu, and Y. Fu, "Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes," Life Sciences, vol. 77, no. 2, pp. 149-159, 2005.
27. R. H. Boger, S. M. Bode-Boger, A. Szuba et al., "Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia," Circulation, vol. 98, no. 18, pp. 1842-1847, 1998.
28. J. R. McDermott, "Studies on the catabolism of Ngmethylarginine, Ng, Ng-dimethylarginine and Ng, Ngdimethylarginine in the rabbit," Biochemical Journal, vol. 154, no. 1, pp. 179-184, 1976.
29. S. A. Fickling, A. M. Leone, S. S. Nussey, P. Vallance, and G. J. Whitley St, "Synthesis of NG, NG dimethylarginine by human endothelial cells," Endothelium: Journal of Endothelial Cell Research, vol. 1, no. 3, pp. 137-140, 1993.
30. H. Azuma, J. Sato, H. Hamaski, A. Sugimoto, E. Isotani, and S. Obayashi, "Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells," British Journal of Pharmacology, vol. 115, no. 6, pp. 1001-1004, 1995.
31. A. N. Elias and S. Eng, "Homocysteine concentrations in patients with diabetes mellitus-relationship to microvascular and macrovascular disease," Diabetes, Obesity and Metabolism, vol. 7, no. 2, pp. 117-121, 2005.
32. M. Brownlee, "The pathobiology of diabetic complications: a unifying mechanism," Diabetes, vol. 54, no. 6, pp. 1615-1625, 2005.
33. N. E. Cameron, M. A. Cotter, M. Basso, and T. C. Hohman, "Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats," Diabetologia, vol. 40, no. 3, pp. 271-281, 1997.
34. J. Škrha, M. Pr'azn'y, J. Hilgertov'a, and H. Weiserov'a, "Serum α-tocopherol and ascorbic acid concentrations in Type 1 and Type 2 diabetic patients with and without angiopathy," Clinica Chimica Acta, vol. 329, no. 1-2, pp. 103-108, 2003.
35. M. C. S'anchez-Hueso, J. Mateo-Caãs, and E. Zamora-Madaria, "Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetylglucosaminidase (NAG) in diabetes mellitus," Anales de Medicina Interna, vol. 12, no. 5, pp. 216-220, 1995.
36. J. Skrha, M. Pr'azn'y, J. Kvasnicka, and B. Kalvodov'a, "Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy," Časopis L'ekařu Česk'ych, vol. 140, no. 12, pp. 370-374, 2001.
37. J. Škrha, M. Pr'azn'y, T. Haas, J. Kvasnička, and B. Kalvodov'a, "Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients," Journal of Diabetes and its Complications, vol. 15, no. 5, pp. 234-240, 2001.
38. T. Inoue, R.Matsunaga, S.Morooka, and Y. Uehara, "Serum Nacetyl-β-D-gulucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease," Atherosclerosis, vol. 149, no. 1, pp. 117-122, 2000.
39. K. Komosi'nska-Vassev, K. Olczyk, E. M. Ko'zma, P. Olczyk, G. Wisowski, and K.Winsz-Szczotka, "Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control," Clinical Chemistry and Laboratory Medicine, vol. 43, no. 9, pp. 924-929, 2005.